Skip to main content
Fig. 4 | Advances in Rheumatology

Fig. 4

From: COVID-19 on patients with immune-mediated rheumatic disease: a comparative study of disease activity, fatigue, and psychological distress over six months

Fig. 4

Distribution and comparison of FACIT (A), DASS21D (B), DASS21A (C) and DASS21S (D) median scores after a 6-month follow-up in patients with rheumatoid arthritis (RA), systemic lupus erythematosus (SLE) and axial spondyloarthritis (axSpA) only in the patient group (IMRD COVID-19 +). FACIT-F: Functional Assessment of Chronic Illness Therapy – Fatigue; DASS-21D: Depression Anxiety and Stress Scale Domain Depression Scale; DASS-21 A: Depression Anxiety and Stress Scale Domain Anxiety Scale; DASS-21 S: Depression Anxiety and Stress Scale Domain Stress Scale; PsoA: psoriatic arthritis; RA: rheumatoid arthritis; axSpA: axial spondyloarthritis; SLE: systemic lupus erythematosus. Independent-samples Kruskal‒Wallis test, 95% CI

Back to article page

Advances in Rheumatology

ISSN: 2523-3106